Cargando…
SAT-166 Advantage and Trustworthy of Cortisol and Dexamethasone Evaluation in Different Biological Matrices in Patients with Adrenal Masses
Biochemical function of adrenal masses is currently based on 1mg post-overnight dexamethasone suppression test (pDST). Several approaches are recently developed, in order to reduce false positive/negative samples, only in retrospective series. They are based on the correlation of some different para...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207289/ http://dx.doi.org/10.1210/jendso/bvaa046.1680 |
_version_ | 1783530570366582784 |
---|---|
author | Lionetto, Luana Maggio, Roberta Lardo, Pina Bernardini, Donatella De Cipolla, Fabiola Capi, Matilde Simmaco, Maurizio Petrangeli, Elisa Toscano, Vincenzo Pugliese, Giuseppe Stigliano, Antonio |
author_facet | Lionetto, Luana Maggio, Roberta Lardo, Pina Bernardini, Donatella De Cipolla, Fabiola Capi, Matilde Simmaco, Maurizio Petrangeli, Elisa Toscano, Vincenzo Pugliese, Giuseppe Stigliano, Antonio |
author_sort | Lionetto, Luana |
collection | PubMed |
description | Biochemical function of adrenal masses is currently based on 1mg post-overnight dexamethasone suppression test (pDST). Several approaches are recently developed, in order to reduce false positive/negative samples, only in retrospective series. They are based on the correlation of some different parameters, i.e. late-night salivary cortisol (LNSC) vs serum and salivary cortisol pDST; LNSC vs serum and salivary cortisol and serum dexamethasone pDST; LNSC and cortisone vs serum cortisol and salivary cortisol and cortisone pDST. Although these findings offer a better diagnostic performance, several conditions are still disappointed. No information is traceable about the harvest time of diurnal salivary and serum samples and no study include neither the levels of salivary nor urinary dexamethasone pDST. Aim of our study is to combine all these strategies in order to avoid the underestimated biases and obtain more precise information about the true “cortisol condition” of the patients. To reach this purpose we assess both cortisol and dexamethasone concentrations in several samples: saliva at 11PM before the drug administration, diurnal saliva and serum at 8AM and also the urine collection from 11PM to 8AM. Analytes levels are measured using a validated liquid chromatography-tandem mass spectrometry method. In this study we included 20 subjects without morphological adrenal alteration (MRI assessment), dyslipidemia, hypertension and impaired glucose tolerance (healthy controls) and 20 patients with adrenal incidentaloma showing different cortisol levels ranging from normal to ACTH-independent hypercortisolism. In both series, LNSC were similar to salivary cortisol pDST, even if they were greater in the patients with adrenal incidentalomas and subclinical cortisol secretion. Serum dexamethasone levels were in reference ranges, while salivary and urinary dexamethasone found in these matrices require additional sample numbers in order to establish appropriate cut-offs. Our preliminary results suggest that the combination of these findings could represent an improvement to assess the individual cortisol status. |
format | Online Article Text |
id | pubmed-7207289 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-72072892020-05-12 SAT-166 Advantage and Trustworthy of Cortisol and Dexamethasone Evaluation in Different Biological Matrices in Patients with Adrenal Masses Lionetto, Luana Maggio, Roberta Lardo, Pina Bernardini, Donatella De Cipolla, Fabiola Capi, Matilde Simmaco, Maurizio Petrangeli, Elisa Toscano, Vincenzo Pugliese, Giuseppe Stigliano, Antonio J Endocr Soc Adrenal Biochemical function of adrenal masses is currently based on 1mg post-overnight dexamethasone suppression test (pDST). Several approaches are recently developed, in order to reduce false positive/negative samples, only in retrospective series. They are based on the correlation of some different parameters, i.e. late-night salivary cortisol (LNSC) vs serum and salivary cortisol pDST; LNSC vs serum and salivary cortisol and serum dexamethasone pDST; LNSC and cortisone vs serum cortisol and salivary cortisol and cortisone pDST. Although these findings offer a better diagnostic performance, several conditions are still disappointed. No information is traceable about the harvest time of diurnal salivary and serum samples and no study include neither the levels of salivary nor urinary dexamethasone pDST. Aim of our study is to combine all these strategies in order to avoid the underestimated biases and obtain more precise information about the true “cortisol condition” of the patients. To reach this purpose we assess both cortisol and dexamethasone concentrations in several samples: saliva at 11PM before the drug administration, diurnal saliva and serum at 8AM and also the urine collection from 11PM to 8AM. Analytes levels are measured using a validated liquid chromatography-tandem mass spectrometry method. In this study we included 20 subjects without morphological adrenal alteration (MRI assessment), dyslipidemia, hypertension and impaired glucose tolerance (healthy controls) and 20 patients with adrenal incidentaloma showing different cortisol levels ranging from normal to ACTH-independent hypercortisolism. In both series, LNSC were similar to salivary cortisol pDST, even if they were greater in the patients with adrenal incidentalomas and subclinical cortisol secretion. Serum dexamethasone levels were in reference ranges, while salivary and urinary dexamethasone found in these matrices require additional sample numbers in order to establish appropriate cut-offs. Our preliminary results suggest that the combination of these findings could represent an improvement to assess the individual cortisol status. Oxford University Press 2020-05-08 /pmc/articles/PMC7207289/ http://dx.doi.org/10.1210/jendso/bvaa046.1680 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Adrenal Lionetto, Luana Maggio, Roberta Lardo, Pina Bernardini, Donatella De Cipolla, Fabiola Capi, Matilde Simmaco, Maurizio Petrangeli, Elisa Toscano, Vincenzo Pugliese, Giuseppe Stigliano, Antonio SAT-166 Advantage and Trustworthy of Cortisol and Dexamethasone Evaluation in Different Biological Matrices in Patients with Adrenal Masses |
title | SAT-166 Advantage and Trustworthy of Cortisol and Dexamethasone Evaluation in Different Biological Matrices in Patients with Adrenal Masses |
title_full | SAT-166 Advantage and Trustworthy of Cortisol and Dexamethasone Evaluation in Different Biological Matrices in Patients with Adrenal Masses |
title_fullStr | SAT-166 Advantage and Trustworthy of Cortisol and Dexamethasone Evaluation in Different Biological Matrices in Patients with Adrenal Masses |
title_full_unstemmed | SAT-166 Advantage and Trustworthy of Cortisol and Dexamethasone Evaluation in Different Biological Matrices in Patients with Adrenal Masses |
title_short | SAT-166 Advantage and Trustworthy of Cortisol and Dexamethasone Evaluation in Different Biological Matrices in Patients with Adrenal Masses |
title_sort | sat-166 advantage and trustworthy of cortisol and dexamethasone evaluation in different biological matrices in patients with adrenal masses |
topic | Adrenal |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207289/ http://dx.doi.org/10.1210/jendso/bvaa046.1680 |
work_keys_str_mv | AT lionettoluana sat166advantageandtrustworthyofcortisolanddexamethasoneevaluationindifferentbiologicalmatricesinpatientswithadrenalmasses AT maggioroberta sat166advantageandtrustworthyofcortisolanddexamethasoneevaluationindifferentbiologicalmatricesinpatientswithadrenalmasses AT lardopina sat166advantageandtrustworthyofcortisolanddexamethasoneevaluationindifferentbiologicalmatricesinpatientswithadrenalmasses AT bernardinidonatellade sat166advantageandtrustworthyofcortisolanddexamethasoneevaluationindifferentbiologicalmatricesinpatientswithadrenalmasses AT cipollafabiola sat166advantageandtrustworthyofcortisolanddexamethasoneevaluationindifferentbiologicalmatricesinpatientswithadrenalmasses AT capimatilde sat166advantageandtrustworthyofcortisolanddexamethasoneevaluationindifferentbiologicalmatricesinpatientswithadrenalmasses AT simmacomaurizio sat166advantageandtrustworthyofcortisolanddexamethasoneevaluationindifferentbiologicalmatricesinpatientswithadrenalmasses AT petrangelielisa sat166advantageandtrustworthyofcortisolanddexamethasoneevaluationindifferentbiologicalmatricesinpatientswithadrenalmasses AT toscanovincenzo sat166advantageandtrustworthyofcortisolanddexamethasoneevaluationindifferentbiologicalmatricesinpatientswithadrenalmasses AT pugliesegiuseppe sat166advantageandtrustworthyofcortisolanddexamethasoneevaluationindifferentbiologicalmatricesinpatientswithadrenalmasses AT stiglianoantonio sat166advantageandtrustworthyofcortisolanddexamethasoneevaluationindifferentbiologicalmatricesinpatientswithadrenalmasses |